On specialist advice

MHRA Advice
MHRA advises that when prescribing for epilepsy the patient should be assessed to make a clinical judgement if the same manufacturer's product/brand is necessary taking into account factors such as seizure frequency and treatment history. Also take into account patient/carer related factors such as their negative perceptions about alternative products and/or other issues related to the patient such as co-morbid autism, mental health issues or learning disability